| |
|
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
Dementia-research |
|
|
|
Sunset Redfish Bay Fort
Myers, Florida photo by
Marty L. Hinz, MD |
|
|
|
Dementia |
 |
|
|
Contact us or find
a caregiver using this approach. |
|
|
DEMENTIA |
|
Written by:
Marty L. Hinz, MD |
|
President
Clinical
Research |
|
NeuroResearch
Clinics,
Inc. |
|
|
Cape Coral,
Florida USA
Research
Office |
|
|
|
|
Real treatment of dementia, where
brain function is
truly restored and controlled, has
eluded medicine.
The NeuroResearch
Clinics approach
produces excellent results in
dementia patients.
DEMENTIA
The NeuroResearch
Clinics approach in
treatment of
patients with
dementia
involves
neurotransmitter
optimization
treatment of the
master
neurotransmitters of
the brain serotonin,
dopamine,
norepinephrine and
epinephrine. These
neurotransmitters
directly and
indirectly control
virtually every
function in the
brain and body.
NeuroResearch
Clinics uses 5-HTP,
tyrosine, levodopa,
and cysteine guided
by neurotransmitter
testing as indicted
to restore brain
function and get
other symptoms
associated with
dementia
under control. Most
dementia patients
show
significant improvement of
cognitive brain
function. 15%
to 20% of
patients with
dementia
achieve
profound restoration
of brain
function. Please,
read the case
studies in the right
brown colored
column, these were
written by medical
doctors (MDs) based
on medical care
experiences.
Restoration of
the brain in
patients suffer from
dementia
neurotransmitter
optimization
treatment is in a
league of its own,
beyond results seen
with any
prescription drug in
the past.
|
|
|
|
DEMENTIA
SYMPTOMS
While deterioration of
brain function takes
the spot light in
patients suffering
from
dementia
there are many
other problems that
can be active,
including:
-
Sleep
patterns,
Many
patients with
dementia
suffer
from
abnormal
sleep
patterns, up
during
the
night
wandering
around
or
sleeping
during
the day.
With
serotonin
and
dopamine
optimization
treatment normal
sleep
patterns
are
restored
in the
dementia
patient.
-
Inappropriate
anger,
aggression,
or
yelling
out,
is a
problem
with some
suffering from dementia.
With
serotonin
and
dopamine
optimization
treatment
inappropriate
anger,
aggression,
or
yelling
out are
controlled
in the
patient.
-
Agitation,
many
patients with dementia
suffer
from
inappropriate
agitation.
This may
take the
form of
mental
or
physical
agitation.
With
serotonin
and
dopamine
optimization
treatment
agitation
is
controlled
in the patient.
-
Depression
is
common
in
patients with dementia.
Depression may
display
as an
agitated
depression.
In
medicine
there is
no drug that
effectively
controls
depression
in the
elderly, with
or
without
dementia.
With
neurotransmitter
optimization
treatment
of serotonin
and
dopamine
guided
by
neurotransmitter
testing
when
indicated
depression
is
controlled.
-
Anxiety, may be present.
With
neurotransmitter
optimization
treatment
of serotonin
and
dopamine
guided
by
neurotransmitter
testing
as
indicted, anxiety
in the
patient
with
dementia
may be
controlled.
-
Psychotic state is a significant problem with
patients talking
about
and hearing or
seeing
things
that are
not
there.
With
neurotransmitter
optimization
treatment
of serotonin
and
dopamine
guided
by
neurotransmitter
testing
as
indicated,
the
patient
with
dementia
may
experience
control
of
inappropriate
perceptions.
-
Restless
Leg
Syndrome
is
common,
contributing
greatly
sleep
disturbance
which
leads to
exacerbation
of
cognitive
problems.
With
neurotransmitter
optimization
treatment
of
serotonin
and
dopamine
guided
by
neurotransmitter
testing
as
indicted,
Restless
Leg
Syndrome
in the
patient
with
dementia
can be
controlled.
Dementia
research |
|
|
|
|
WHAT CAUSES
DEMENTIA?
Elevation of
neurotransmitter
levels,
guided by
neurotransmitter
testing,
reveals
excellent
results in
patients
suffering
with
dementia.
Review of
neurotransmitter
testing
prior to
treatment
reveals that
patients
with
dementia,
as a group,
have
virtually
the same
neurotransmitter
levels as
those that
do not.
Therefore
low levels
of
neurotransmitters
is not the
cause of
dementia.
The primary
cause of
dementia
appears
to be brain
damage. The
leading
cause is
neurotoxic
damage. Just
as with
Parkinson's
Disease
patients
elevating
neurotransmitter
levels
restores
flow of
electricity
in the brain
compensating
for brain
damage,
restoring
normal
function,
and
relieving
symptoms.
Dementia
Links
Dementia
organization
Dementia
Medline
Dementia
Mayo
Dementia
Foundation
Dementia
news
|
|
|
